---
created: 2025-04-13
updated: 2025-04-13T10:52
id: E~vb,mV+zs
specialty: endo
specialty_id: 90
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::08-endocrine::05-pharm::04-hypothalamic-pituitary-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::08-endocrine::05-pharm::04-hypothalamic-pituitary-drugs::mecasermin
  - "source/ak-step1-v11:": 
  - theme/nbme::26
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::05-gi-&-endocrine::04-hypothalamic-&-pituitary::01-growth-hormone,-mecasermin,-octreotide,-pegvisomant
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::endocrine::pharmacology
type: flashcard
---

# Question
**Mecasermin** is a recombinant form of **IGF-1** that may be used to treat growth failure due to severe **IGF-1** deficiency

---

# Answer
IGF-1 Insulin-like growth factor-1 is regulated by GH, and produced by the liver  - decd IGF-1 *liver production* == decreased axial and appendicular skeletal growth.